Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03044782 · ClinicalTrials.gov registry record

Barriers to Care and QOL for CCCA Patients

A clinical trial, sponsored by Northwestern University.

Completed
Registry status
34
Enrollment target

NCT03044782 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 34 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03044782 has completed, sponsored by Northwestern University.

COMPLETED
Registry status
34 participants
Enrollment target

Study Summary

The purpose of the current project is twofold; first to determine what personal, historical, logistical, and environmental factors preclude women from obtaining medical care for CCCA hair loss. Because damage from CCCA is irreversible, early identification and treatment is paramount to limiting the negative ramifications of the disease. Second, to investigate how CCCA hair loss, a common occurrence in the Black population, can be a significant psychological impediment to lives of affected Black women. Based on previous research on the psychosocial impact of generalized hair loss in Black women, it is fair to consider that CCCA hair loss also leads to problems with self-esteem and participation in daily life activities. This research, the first of its kind, will add to existing knowledge of CCCA by investigating the quality of life and barriers to care of patients with this condition. The goal of this study is to illuminate what stands in the way of secondary and tertiary prevention of CCCA patients and tailor treatment strategies to address their needs. The results of this study will be instrumental in modifying dermatology resident training, adding to existing dermatology management guidelines, and even developing public health advocacy programming.

Interventions

  • OTHER 53-Item Survey

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2016-08
Est. Completion 2017-09

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT03044782

The ClinicalTrials.gov registry entry for NCT03044782 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which 53-Item Survey is the first listed.

NCT03044782 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03044782 about?

NCT03044782 is a clinical study titled "Barriers to Care and QOL for CCCA Patients". The purpose of the current project is twofold; first to determine what personal, historical, logistical, and environmental factors preclude women from obtaining medical care for CCCA hair loss. Because damage from CCCA is irreversible, early identification and treatment is paramount to limiting the ...

What is the current status of trial NCT03044782?

This trial is currently completed. The enrollment target is 34 participants. The study started on 2016-08. Estimated completion is 2017-09.

What interventions are being tested in trial NCT03044782?

The interventions under investigation include: 53-Item Survey (OTHER).

Who is sponsoring clinical trial NCT03044782?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.